195 related articles for article (PubMed ID: 25340858)
41. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study.
Tantawy MA; El-Sherbeeny NA; Helmi N; Alazragi R; Salem N; Elaidy SM
Mol Cell Biochem; 2020 Jun; 469(1-2):143-157. PubMed ID: 32356241
[TBL] [Abstract][Full Text] [Related]
42. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.
Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB
J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435
[TBL] [Abstract][Full Text] [Related]
43. Progress in studies on the DEK protein and its involvement in cellular apoptosis.
Hua Y; Hu H; Peng X
Sci China C Life Sci; 2009 Jul; 52(7):637-42. PubMed ID: 19641868
[TBL] [Abstract][Full Text] [Related]
44. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
Datta A; Adelson ME; Mogilevkin Y; Mordechai E; Sidi AA; Trama JP
BMC Cancer; 2011 Jun; 11():234. PubMed ID: 21663673
[TBL] [Abstract][Full Text] [Related]
45. Lysine-specific histone demethylase 1B (LSD2/KDM1B) represses p53 expression to promote proliferation and inhibit apoptosis in colorectal cancer through LSD2-mediated H3K4me2 demethylation.
Cai S; Wang J; Zeng W; Cheng X; Liu L; Li W
Aging (Albany NY); 2020 Jul; 12(14):14990-15001. PubMed ID: 32726297
[TBL] [Abstract][Full Text] [Related]
46. The unique DEK oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo.
Wise-Draper TM; Mintz-Cole RA; Morris TA; Simpson DS; Wikenheiser-Brokamp KA; Currier MA; Cripe TP; Grosveld GC; Wells SI
Cancer Res; 2009 Mar; 69(5):1792-9. PubMed ID: 19223548
[TBL] [Abstract][Full Text] [Related]
48. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.
Fahrer J; Popp O; Malanga M; Beneke S; Markovitz DM; Ferrando-May E; Bürkle A; Kappes F
Biochemistry; 2010 Aug; 49(33):7119-30. PubMed ID: 20669926
[TBL] [Abstract][Full Text] [Related]
49. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt.
Zalata KR; Nasif WA; Ming SC; Lotfy M; Nada NA; El-Hak NG; Leech SH
Cell Oncol; 2005; 27(4):245-53. PubMed ID: 16308474
[TBL] [Abstract][Full Text] [Related]
50. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
51. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
Kikuchi Y; Dinjens WN; Bosman FT
Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
53. Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model.
Pierzynska-Mach A; Cainero I; Oneto M; Ferrando-May E; Lanzanò L; Diaspro A
Sci Rep; 2023 Aug; 13(1):12749. PubMed ID: 37550322
[TBL] [Abstract][Full Text] [Related]
54. DEK is required for homologous recombination repair of DNA breaks.
Smith EA; Gole B; Willis NA; Soria R; Starnes LM; Krumpelbeck EF; Jegga AG; Ali AM; Guo H; Meetei AR; Andreassen PR; Kappes F; Vinnedge LM; Daniel JA; Scully R; Wiesmüller L; Wells SI
Sci Rep; 2017 Mar; 7():44662. PubMed ID: 28317934
[TBL] [Abstract][Full Text] [Related]
55. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
56. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
57. p300/CBP-associated factor drives DEK into interchromatin granule clusters.
Cleary J; Sitwala KV; Khodadoust MS; Kwok RP; Mor-Vaknin N; Cebrat M; Cole PA; Markovitz DM
J Biol Chem; 2005 Sep; 280(36):31760-7. PubMed ID: 15987677
[TBL] [Abstract][Full Text] [Related]
58. Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway.
Tian Y; Shen L; Li F; Yang J; Wan X; Ouyang M
J Cell Physiol; 2020 Jan; 235(1):442-453. PubMed ID: 31332784
[TBL] [Abstract][Full Text] [Related]
59. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
60. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]